Percutaneous vertebroplasty in osteoporosis, myeloma and Langerhans' cell histiocytosis.

Hdl Handle:
http://hdl.handle.net/10147/200969
Title:
Percutaneous vertebroplasty in osteoporosis, myeloma and Langerhans' cell histiocytosis.
Authors:
Kevane, B; Ryder, D Q; Gilligan, O
Affiliation:
Department of Haematology, Cork University Hospital, Wilton, Cork. barrykevane@hotmail.com
Citation:
Percutaneous vertebroplasty in osteoporosis, myeloma and Langerhans' cell histiocytosis., 102 (7):212-5 Ir Med J
Journal:
Irish medical journal
Issue Date:
9-Jan-2012
URI:
http://hdl.handle.net/10147/200969
PubMed ID:
19772001
Abstract:
This review aims to assess the effectiveness of percutaneous vertebroplasty as a treatment for the severe refractory pain associated with vertebral fracture, in a group of patients with fractures secondary to either osteoporotic or neoplastic disease. A retrospective review of 20 patients treated with percutaneous vertebroplasty in Cork University Hospital up until March 2007 was carried out and a questionnaire was prepared and distributed. Prior to vertebroplasty, patients had been symptomatic with severe pain for a mean of 20.9 weeks. Of those thirteen whom replied to a postal questionnaire, 12 (92.3%) reported pain relief and this improvement occurred within 7 days in 9 (81.8%). This was associated with decreased analgesic requirements, as determined on chart review. Prior to the procedure only 5 (38.4%) were independently mobile and this figure rose to 10 (76.9%) afterwards, occurring within one week in the majority. Subjective outcomes were better in the group of patients with neoplasm-induced fractures.
Item Type:
Article
Language:
en
Description:
This review aims to assess the effectiveness of percutaneous vertebroplasty as a treatment for the severe refractory pain associated with vertebral fracture, in a group of patients with fractures secondary to either osteoporotic or neoplastic disease. A retrospective review of 20 patients treated with percutaneous vertebroplasty in Cork University Hospital up until March 2007 was carried out and a questionnaire was prepared and distributed. Prior to vertebroplasty, patients had been symptomatic with severe pain for a mean of 20.9 weeks. Of those thirteen whom replied to a postal questionnaire, 12 (92.3%) reported pain relief and this improvement occurred within 7 days in 9 (81.8%). This was associated with decreased analgesic requirements, as determined on chart review. Prior to the procedure only 5 (38.4%) were independently mobile and this figure rose to 10 (76.9%) afterwards, occurring within one week in the majority. Subjective outcomes were better in the group of patients with neoplasm-induced fractures.
MeSH:
Aged; Cohort Studies; Female; Fractures, Bone; Histiocytosis, Langerhans-Cell; Humans; Male; Multiple Myeloma; Osteoporosis; Questionnaires; Retrospective Studies; Treatment Outcome; Vertebroplasty
ISSN:
0332-3102

Full metadata record

DC FieldValue Language
dc.contributor.authorKevane, Ben
dc.contributor.authorRyder, D Qen
dc.contributor.authorGilligan, Oen
dc.date.accessioned2012-01-09T15:47:31Z-
dc.date.available2012-01-09T15:47:31Z-
dc.date.issued2012-01-09T15:47:31Z-
dc.identifier.citationPercutaneous vertebroplasty in osteoporosis, myeloma and Langerhans' cell histiocytosis., 102 (7):212-5 Ir Med Jen
dc.identifier.issn0332-3102-
dc.identifier.pmid19772001-
dc.identifier.urihttp://hdl.handle.net/10147/200969-
dc.descriptionThis review aims to assess the effectiveness of percutaneous vertebroplasty as a treatment for the severe refractory pain associated with vertebral fracture, in a group of patients with fractures secondary to either osteoporotic or neoplastic disease. A retrospective review of 20 patients treated with percutaneous vertebroplasty in Cork University Hospital up until March 2007 was carried out and a questionnaire was prepared and distributed. Prior to vertebroplasty, patients had been symptomatic with severe pain for a mean of 20.9 weeks. Of those thirteen whom replied to a postal questionnaire, 12 (92.3%) reported pain relief and this improvement occurred within 7 days in 9 (81.8%). This was associated with decreased analgesic requirements, as determined on chart review. Prior to the procedure only 5 (38.4%) were independently mobile and this figure rose to 10 (76.9%) afterwards, occurring within one week in the majority. Subjective outcomes were better in the group of patients with neoplasm-induced fractures.en
dc.description.abstractThis review aims to assess the effectiveness of percutaneous vertebroplasty as a treatment for the severe refractory pain associated with vertebral fracture, in a group of patients with fractures secondary to either osteoporotic or neoplastic disease. A retrospective review of 20 patients treated with percutaneous vertebroplasty in Cork University Hospital up until March 2007 was carried out and a questionnaire was prepared and distributed. Prior to vertebroplasty, patients had been symptomatic with severe pain for a mean of 20.9 weeks. Of those thirteen whom replied to a postal questionnaire, 12 (92.3%) reported pain relief and this improvement occurred within 7 days in 9 (81.8%). This was associated with decreased analgesic requirements, as determined on chart review. Prior to the procedure only 5 (38.4%) were independently mobile and this figure rose to 10 (76.9%) afterwards, occurring within one week in the majority. Subjective outcomes were better in the group of patients with neoplasm-induced fractures.-
dc.language.isoenen
dc.subject.meshAged-
dc.subject.meshCohort Studies-
dc.subject.meshFemale-
dc.subject.meshFractures, Bone-
dc.subject.meshHistiocytosis, Langerhans-Cell-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshMultiple Myeloma-
dc.subject.meshOsteoporosis-
dc.subject.meshQuestionnaires-
dc.subject.meshRetrospective Studies-
dc.subject.meshTreatment Outcome-
dc.subject.meshVertebroplasty-
dc.titlePercutaneous vertebroplasty in osteoporosis, myeloma and Langerhans' cell histiocytosis.en
dc.typeArticleen
dc.contributor.departmentDepartment of Haematology, Cork University Hospital, Wilton, Cork. barrykevane@hotmail.comen
dc.identifier.journalIrish medical journalen
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.